| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.3 |